Investment Analysis / March 2026

ViewsML Technologies

AI-powered virtual immunohistochemistry for spatial biology and companion diagnostics. Seed-stage company assessment using the Peerlabs Four Axes methodology.

Vancouver, BC — Founded April 2022 — Virtual IHC / Spatial Biology AI — ~$4M raised

Investment Brief
ViewsML Technologies
Four Axes assessment as a potential investment target. Synthesizes the May 2023 pitch deck, verified competitive intelligence, and the Peerlabs market comparison. Confidence levels reflect evidence quality.
Four Axes Internal Only
→
Company Dossier
Intelligence Dossier
Full signal provenance, structured assessment, competing interpretations, and confidence dimensions. Covers notable events, synthesized understanding, and decision-relevant findings.
DOS-2026-03-001 Low-Mod Confidence
→
Market Comparison
Virtual IHC vs. Clinical AI Pathology
Market context covering the competitive landscape, evidence standards, foundation model commoditization, and the August 2025 consolidation event that restructured the sector.
Primary Sources Companion
→
Methodology
fabric Inc. vs ViewsML
Meta-analytical comparison of the first two full applications of the Peerlabs company intelligence pipeline. Extracts methodology lessons across different entity stages and research access levels.
Pipeline Review Two Engagements
→